Bias risk assessments for each RCS study. by Xin Liu (43569)

Subjects:

Summary of results. by Xin Liu (43569)

Subjects:

NREM 1/f slopes calculated from Power Spectrum Densities (PSDs) have a robust nocturnal rhythm at low frequencies that are initially flattened during spontaneous oxycodone withdraw... by Michael Gulledge (20577135)

Subjects:

Spontaneous oxycodone withdrawal transiently eliminates diurnal changes in NREM depth. by Michael Gulledge (20577135)

Subjects:

Spontaneous oxycodone withdrawal disrupts sleep/wake architecture. by Michael Gulledge (20577135)

Subjects:

Association of <i>Shigella</i> infections with EE biomarker concentration over time. by Haley A. Liakakos (21445884)

Subjects:

Associations between <i>Shigella</i> infections and EE biomarker concentrations from time of index subclinical <i>Shigella</i> detection through 6-months post-detection, stratified... by Haley A. Liakakos (21445884)

Subjects:

Characteristics of non-diarrheal stool samples from 1715 children in MAL-ED study. by Haley A. Liakakos (21445884)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

Estimated marginal means (± SE) of durations of momentary frequency of highest amplitude (MFHA). by Micha Keller (11312748)

“…The most marked change can be seen during CVH intervention, with a significant increase in LF and a significant decrease in IM duration.…”

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and Post-Treatment Myocardial Perfusion Defects Expressed as a Percentage of the Total Left Ventricular Surface Area in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and post-treatment results of quantitative electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

CONSORT diagram illustrating patient flow during the study. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Clinical and Demographic Characteristics of the Study Population. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Variables obtained from the SF-36 quality of life questionnaire in each experimental group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. by Káryta Suely Macêdo Martins (22404155)

Subjects: